https://bibliography.nanobiotix.com/2019-astro-nbtxr3-for-the-treatment-of-locally-advanced-hnscc/
2019-astro-nbtxr3-for-the-treatment-of-locally-advanced-hnscc | Nano Publications
for the
https://lifestyle.kotaradio.com/story/174686/pyxis-oncology-to-present-new-preclinical-data-showing-synergistic-anti-tumor-activity-in-a-hnscc-model-with-mamicvo-in-combination-with-anti-pd-1-at-aacr-2026/
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC...
https://www.fortificlinicaltrial.com/
HNSCC Clinical Trial Now Enrolling Near You
Seeking patients who have been diagnosed with non-HPV head and neck cancer (HNSCC) for a new clinical trial. Click to learn more about the study.
clinical trialnow enrollingnear
https://www.cancernetwork.com/view/sacituzumab-govitecan-displays-antitumor-activity-in-advanced-hnscc
Sacituzumab Govitecan Displays Antitumor Activity in Advanced HNSCC | CancerNetwork
May 20, 2026 - Sacituzumab govitecan showed anti-tumor activity in patients with pretreated metastatic or locally recurrent head and neck squamous cell carcinoma.
sacituzumabdisplaysantitumoractivityadvanced
https://nanobiotix.com/resource/echno-2018-nbtxr3-for-elderly-and-frail-hnscc-patients/
ECHNO 2018 - NBTXR3 for elderly and frail HNSCC patients | Nanobiotix
Jun 7, 2018 - Hoffmann C.1, Moreno V.2, Calugaru V.1, Jouffroy T.1, Rodriguez J.1, Calvo E.2, Dodger B.2, Chilles A.1, Khrili S.1, Badois N.1, Lesnik M.1 and Le Tourneau ...
for elderlyfrailpatientsnanobiotix
https://aging-us.org/2024/02/senescence-related-tme-genes-as-key-prognostic-predictors-in-hnscc/
Senescence-Related TME Genes as Key Prognostic Predictors in HNSCC - Aging-US Research
Feb 1, 2024 - In a new study, researchers investigated the prognostic significance of senescence-related TME genes in head and neck squamous cell carcinoma (HNSCC) and their...
https://visualping.io/pages/pembrolizumab-for-hnscc-residual-disease-clinical-trial-alerts-4961585
Pembrolizumab for HNSCC Residual Disease Clinical Trial: Get alerts for the latest updates -...
See the latest updates to Pembrolizumab for HNSCC Residual Disease Clinical Trial. Subscribe for free to get alerts when changes are detected to Pembrolizumab...
clinical trial
https://stage.cancerimagingarchive.net/tcia-version-dnlds/cptac-hnscc-ver5-path/
CPTAC-HNSCC-VER5-PATH - The Cancer Imaging Archive (TCIA)
the cancerpathimagingarchive
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-09147
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC - NCI
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC